Capital Impact Advisors’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-147,303
| Closed | -$1.24M | – | 122 |
|
|
2020
Q1 | $1.24M | Buy |
147,303
+8,574
| +6% | +$72.4K | 0.52% | 89 |
|
|
2019
Q4 | $1.21M | Sell |
138,729
-35,912
| -21% | -$314K | 0.43% | 108 |
|
|
2019
Q3 | $1.95M | Buy |
174,641
+47,612
| +37% | +$531K | 0.74% | 70 |
|
|
2019
Q2 | $1.62M | Buy |
127,029
+53,153
| +72% | +$676K | 0.59% | 102 |
|
|
2019
Q1 | $1.56M | Hold |
73,876
| – | – | 0.69% | 76 |
|
|
2018
Q4 | $1.56M | Buy |
73,876
+34,667
| +88% | +$731K | 0.67% | 79 |
|
|
2018
Q3 | $1.8M | Buy |
39,209
+2,912
| +8% | +$133K | 0.62% | 84 |
|
|
2018
Q2 | $2.05M | Buy |
36,297
+10,068
| +38% | +$567K | 0.76% | 47 |
|
|
2018
Q1 | $1.79M | Buy |
26,229
+11,320
| +76% | +$770K | 0.73% | 48 |
|
|
2017
Q4 | $1.47M | Hold |
14,909
| – | – | 0.64% | 69 |
|
|
2017
Q3 | $1.79M | Sell |
14,909
-3,965
| -21% | -$475K | 0.8% | 37 |
|
|
2017
Q2 | $1.65M | Sell |
18,874
-7,231
| -28% | -$632K | 0.75% | 38 |
|
|
2017
Q1 | $971K | Buy |
+26,105
| New | +$971K | 0.39% | 137 |
|
|
2015
Q4 | – | Sell |
-1,492
| Closed | -$112K | – | 273 |
|
|
2015
Q3 | $112K | Hold |
1,492
| – | – | 0.06% | 254 |
|
|
2015
Q2 | $174K | Hold |
1,492
| – | – | 0.08% | 256 |
|
|
2015
Q1 | $352K | Buy |
+1,492
| New | +$352K | 0.16% | 225 |
|